Ghana vs Sub-Saharan Africa (IDA & IBRD countries): Antiretroviral therapy coverage for PMTCT
Ghana
99.0%
in 2024
Sub-Saharan Africa (IDA & IBRD countries)
89.5%
in 2024
Ghana rank
5th
Sub-Saharan Africa (IDA & IBRD countries) rank
2nd
Antiretroviral therapy coverage for PMTCT over time
- Ghana
- Sub-Saharan Africa (IDA & IBRD countries)
How they compare
Ghana currently reports 99.0% against 89.5% in Sub-Saharan Africa (IDA & IBRD countries), a difference of 9.5%.
That makes Ghana's figure about 1.1 times Sub-Saharan Africa (IDA & IBRD countries)'s.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Sub-Saharan Africa (IDA & IBRD countries) ahead.
Ghana ranks 5th and Sub-Saharan Africa (IDA & IBRD countries) ranks 2nd of 84 countries.
Across the 3 decades both report, Ghana averaged higher in 1 and Sub-Saharan Africa (IDA & IBRD countries) in 2.
Head to head by decade
| Decade | Ghana | Sub-Saharan Africa (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.6% | 20.9% | 11.3% | Sub-Saharan Africa (IDA & IBRD countries) |
| 2010s | 59.9% | 78.2% | 18.3% | Sub-Saharan Africa (IDA & IBRD countries) |
| 2020s | 89.0% | 88.6% | 0.4% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Ghana or Sub-Saharan Africa (IDA & IBRD countries)?
- Ghana, at 99.0% against 89.5% in Sub-Saharan Africa (IDA & IBRD countries) as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Ghana and Sub-Saharan Africa (IDA & IBRD countries)?
- 9.5%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Sub-Saharan Africa (IDA & IBRD countries)?
- 25 years are reported by both, from 2000 to 2024.
- How do Ghana and Sub-Saharan Africa (IDA & IBRD countries) rank globally for antiretroviral therapy coverage for pmtct?
- Ghana ranks 5th and Sub-Saharan Africa (IDA & IBRD countries) ranks 2nd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).